Wednesday, Given Imaging Ltd. (GIVN), a gastrointestinal diagnosis products maker, reported an increase in second quarter earnings helped by a 19% increase in sales driven by robust global demand for PillCam SB in its three operating regions.
Net income for the second quarter ended June 30, 2008 surged to $2.9 million or $0.09 per share from $0.62 million or $0.02 per share in the prior year period and exceeded $0.02 per share projected by five analysts surveyed by First Call/Thomson Financial.
Revenues increased by 19% to $33.1 million from $27.8 million in the comparable period last year and topped six analysts' revenue consensus estimate of $32.07 million.
Sales in the Americas region were $19.7 million, up 7% from the $18.4 million in the same period in 2007. EMEA sales rose 20.3% to $8.3 million from $6.9 million last year, while APAC sales doubled to $5.0 million from $2.5 million in the prior year period.
PillCam sales accounted for 83% of total revenues compared to 86% of total sales in the same period of last year.
Net income for the first six months rose to $4.0 million or $0.13 per share from $0.69 million or $0.02 per share in the year-ago period. Sales increased 18.3% to $60.2 million from $50.9 million last year.
Looking ahead, as a result of settling our patent litigation with Olympus Corporation, the Yoqneam, Israel headquartered company increased full year 2008 earnings per share forecast to $0.34 - $0.42 range from earlier estimate of $0.26 and $0.34 per share. Currently, four analysts surveyed by First Call expect the company to earn $0.08 per share for fiscal 2008.
GIVN declined $0.25 or 1.72% and closed Wednesday's regular trading session at $14.27. After hours, GIVN rose $1.00 or 7.01%and traded at $15.27.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.